Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions.

SPRINT MIND Investigators for the SPRINT Research Group, Nasrallah IM, Pajewski NM, Auchus AP, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Doshi J, Erus G, Fine LJ, Gaussoin SA, Harris D, Johnson KC, Kimmel PL, Kurella Tamura M, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB, Williamson JD, Bryan RN.

JAMA. 2019 Aug 13;322(6):524-534. doi: 10.1001/jama.2019.10551.

PMID:
31408137
2.

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

SPRINT MIND Investigators for the SPRINT Research Group, Williamson JD, Pajewski NM, Auchus AP, Bryan RN, Chelune G, Cheung AK, Cleveland ML, Coker LH, Crowe MG, Cushman WC, Cutler JA, Davatzikos C, Desiderio L, Erus G, Fine LJ, Gaussoin SA, Harris D, Hsieh MK, Johnson KC, Kimmel PL, Tamura MK, Launer LJ, Lerner AJ, Lewis CE, Martindale-Adams J, Moy CS, Nasrallah IM, Nichols LO, Oparil S, Ogrocki PK, Rahman M, Rapp SR, Reboussin DM, Rocco MV, Sachs BC, Sink KM, Still CH, Supiano MA, Snyder JK, Wadley VG, Walker J, Weiner DE, Whelton PK, Wilson VM, Woolard N, Wright JT Jr, Wright CB.

JAMA. 2019 Feb 12;321(6):553-561. doi: 10.1001/jama.2018.21442.

3.

Canvass: A Crowd-Sourced, Natural-Product Screening Library for Exploring Biological Space.

Kearney SE, Zahoránszky-Kőhalmi G, Brimacombe KR, Henderson MJ, Lynch C, Zhao T, Wan KK, Itkin Z, Dillon C, Shen M, Cheff DM, Lee TD, Bougie D, Cheng K, Coussens NP, Dorjsuren D, Eastman RT, Huang R, Iannotti MJ, Karavadhi S, Klumpp-Thomas C, Roth JS, Sakamuru S, Sun W, Titus SA, Yasgar A, Zhang YQ, Zhao J, Andrade RB, Brown MK, Burns NZ, Cha JK, Mevers EE, Clardy J, Clement JA, Crooks PA, Cuny GD, Ganor J, Moreno J, Morrill LA, Picazo E, Susick RB, Garg NK, Goess BC, Grossman RB, Hughes CC, Johnston JN, Joullie MM, Kinghorn AD, Kingston DGI, Krische MJ, Kwon O, Maimone TJ, Majumdar S, Maloney KN, Mohamed E, Murphy BT, Nagorny P, Olson DE, Overman LE, Brown LE, Snyder JK, Porco JA Jr, Rivas F, Ross SA, Sarpong R, Sharma I, Shaw JT, Xu Z, Shen B, Shi W, Stephenson CRJ, Verano AL, Tan DS, Tang Y, Taylor RE, Thomson RJ, Vosburg DA, Wu J, Wuest WM, Zakarian A, Zhang Y, Ren T, Zuo Z, Inglese J, Michael S, Simeonov A, Zheng W, Shinn P, Jadhav A, Boxer MB, Hall MD, Xia M, Guha R, Rohde JM.

ACS Cent Sci. 2018 Dec 26;4(12):1727-1741. doi: 10.1021/acscentsci.8b00747. Epub 2018 Dec 5.

4.

Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).

Johnson KC, Whelton PK, Cushman WC, Cutler JA, Evans GW, Snyder JK, Ambrosius WT, Beddhu S, Cheung AK, Fine LJ, Lewis CE, Rahman M, Reboussin DM, Rocco MV, Oparil S, Wright JT Jr; SPRINT Research Group.

Hypertension. 2018 May;71(5):848-857. doi: 10.1161/HYPERTENSIONAHA.117.10479. Epub 2018 Mar 12.

5.

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

Manier S, Huynh D, Shen YJ, Zhou J, Yusufzai T, Salem KZ, Ebright RY, Shi J, Park J, Glavey SV, Devine WG, Liu CJ, Leleu X, Quesnel B, Roche-Lestienne C, Snyder JK, Brown LE, Gray N, Bradner J, Whitesell L, Porco JA Jr, Ghobrial IM.

Sci Transl Med. 2017 May 10;9(389). pii: eaal2668. doi: 10.1126/scitranslmed.aal2668.

6.

Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention Trial.

Ramsey TM, Snyder JK, Lovato LC, Roumie CL, Glasser SP, Cosgrove NM, Olney CM, Tang RH, Johnson KC, Still CH, Gren LH, Childs JC, Crago OL, Summerson JH, Walsh SM, Perdue LH, Bankowski DM, Goff DC; SPRINT Study Research Group.

Clin Trials. 2016 Jun;13(3):319-30. doi: 10.1177/1740774516631735. Epub 2016 Feb 24.

7.

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT.

N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9. Erratum in: N Engl J Med. 2017 Dec 21;377(25):2506.

8.

Gallium(III)-Promoted Halocyclizations of 1,6-Diynes.

Strom KR, Impastato AC, Moy KJ, Landreth AJ, Snyder JK.

Org Lett. 2015 May 1;17(9):2126-9. doi: 10.1021/acs.orglett.5b00716. Epub 2015 Apr 17.

PMID:
25885017
9.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group.

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404. Epub 2014 Jun 5. Erratum in: Clin Trials. 2017 Apr;14(2):222.

10.

Remodeling of fumagillol: discovery of an oxygen-directed oxidative Mannich reaction.

Grenning AJ, Snyder JK, Porco JA Jr.

Org Lett. 2014 Feb 7;16(3):792-5. doi: 10.1021/ol4035269. Epub 2014 Jan 10.

11.

Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.

Filone CM, Hodges EN, Honeyman B, Bushkin GG, Boyd K, Platt A, Ni F, Strom K, Hensley L, Snyder JK, Connor JH.

Chem Biol. 2013 Mar 21;20(3):424-33. doi: 10.1016/j.chembiol.2013.02.011.

12.

An intramolecular inverse electron demand Diels-Alder approach to annulated α-carbolines.

Ma Z, Ni F, Woo GH, Lo SM, Roveto PM, Schaus SE, Snyder JK.

Beilstein J Org Chem. 2012;8:829-40. Epub 2012 Jun 6.

13.

Reexamining individual differences in women's rape avoidance behaviors.

Snyder JK, Fessler DM.

Arch Sex Behav. 2013 May;42(4):543-51. doi: 10.1007/s10508-012-9987-6. Epub 2012 Jun 22.

PMID:
22722957
14.

Weapons make the man (larger): formidability is represented as size and strength in humans.

Fessler DM, Holbrook C, Snyder JK.

PLoS One. 2012;7(4):e32751. doi: 10.1371/journal.pone.0032751. Epub 2012 Apr 11.

15.

Direct binding of a hepatitis C virus inhibitor to the viral capsid protein.

Kota S, Takahashi V, Ni F, Snyder JK, Strosberg AD.

PLoS One. 2012;7(2):e32207. doi: 10.1371/journal.pone.0032207. Epub 2012 Feb 28.

16.

Remodelling of the natural product fumagillol employing a reaction discovery approach.

Balthaser BR, Maloney MC, Beeler AB, Porco JA Jr, Snyder JK.

Nat Chem. 2011 Dec;3(12):969-73.

17.

Indium(III)-catalyzed hydrative cyclization of 1,7-diynyl ethers.

Gibeau AL, Snyder JK.

Org Lett. 2011 Aug 19;13(16):4280-3. doi: 10.1021/ol201624b. Epub 2011 Jul 15.

PMID:
21761825
18.

Discovery of new antimalarial chemotypes through chemical methodology and library development.

Brown LE, Chih-Chien Cheng K, Wei WG, Yuan P, Dai P, Trilles R, Ni F, Yuan J, MacArthur R, Guha R, Johnson RL, Su XZ, Dominguez MM, Snyder JK, Beeler AB, Schaus SE, Inglese J, Porco JA Jr.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6775-80. doi: 10.1073/pnas.1017666108. Epub 2011 Apr 15.

19.

Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents.

Ni F, Kota S, Takahashi V, Strosberg AD, Snyder JK.

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2198-202. doi: 10.1016/j.bmcl.2011.03.014.

20.

Core as a novel viral target for hepatitis C drugs.

Strosberg AD, Kota S, Takahashi V, Snyder JK, Mousseau G.

Viruses. 2010 Aug;2(8):1734-51. doi: 10.3390/v2081734. Epub 2010 Aug 20.

21.

Enantioselective syntheses of candenatenins B and C using a chiral anthracene auxiliary.

Jones AL, Liu X, Snyder JK.

Tetrahedron Lett. 2010 Feb 17;51(7):1091-1094.

22.

Synthesis of unique scaffolds via Diels-Alder cycloadditions of tetrasubstituted cyclohexadienes.

Jones AL, Snyder JK.

Org Lett. 2010 Apr 2;12(7):1592-5. doi: 10.1021/ol100318f.

23.

A time-resolved fluorescence-resonance energy transfer assay for identifying inhibitors of hepatitis C virus core dimerization.

Kota S, Scampavia L, Spicer T, Beeler AB, Takahashi V, Snyder JK, Porco JA, Hodder P, Strosberg AD.

Assay Drug Dev Technol. 2010 Feb;8(1):96-105. doi: 10.1089/adt.2009.0217.

24.

New small molecule inhibitors of hepatitis C virus.

Wei W, Cai C, Kota S, Takahashi V, Ni F, Strosberg AD, Snyder JK.

Bioorg Med Chem Lett. 2009 Dec 15;19(24):6926-30. doi: 10.1016/j.bmcl.2009.10.070. Epub 2009 Oct 21.

25.

Intramolecular rhodium-catalyzed [2+2+2] cyclizations of diynes with enones.

Jones AL, Snyder JK.

J Org Chem. 2009 Apr 3;74(7):2907-10. doi: 10.1021/jo9001678.

26.

Library synthesis using 5,6,7,8-tetrahydro-1,6-naphthyridines as scaffolds.

Zhou Y, Beeler AB, Cho S, Wang Y, Franzblau SG, Snyder JK.

J Comb Chem. 2008 Jul-Aug;10(4):534-40. doi: 10.1021/cc800038r. Epub 2008 Jun 3.

PMID:
18517255
27.

Anthracene cycloadducts as highly selective chiral auxiliaries.

Liu X, Snyder JK.

J Org Chem. 2008 Apr 4;73(7):2935-8. doi: 10.1021/jo702724t. Epub 2008 Mar 6.

PMID:
18321128
28.
29.
30.

Chiral anthracene and anthrone templates as stereocontrolling elements in Diels-Alder/retro Diels-Alder sequences.

Burgess KL, Corbett MS, Eugenio P, Lajkiewicz NJ, Liu X, Sanyal A, Yan W, Yuan Q, Snyder JK.

Bioorg Med Chem. 2005 Sep 1;13(17):5299-309.

PMID:
16046136
31.

Convergent synthesis of a complex oxime library using chemical domain shuffling.

Su S, Acquilano DE, Arumugasamy J, Beeler AB, Eastwood EL, Giguere JR, Lan P, Lei X, Min GK, Yeager AR, Zhou Y, Panek JS, Snyder JK, Schaus SE, Porco JA Jr.

Org Lett. 2005 Jun 23;7(13):2751-4. Erratum in: Org Lett. 2005 Jul 21;7(15):3391.

PMID:
15957938
32.

A new chiral anthracene for the asymmetric Diels-Alder/retro-Diels-Alder sequence.

Burgess KL, Lajkiewicz NJ, Sanyal A, Yan W, Snyder JK.

Org Lett. 2005 Jan 6;7(1):31-4.

PMID:
15624970
34.
35.

A homo Diels-Alder approach to bicyclo[4.2.1]nonanes.

Ma B, Snyder JK.

Org Lett. 2002 Aug 8;4(16):2731-4.

PMID:
12153221
36.
37.
38.
39.

Resonance Raman studies indicate a unique heme active site in prostaglandin H synthase.

Lou BS, Snyder JK, Marshall P, Wang JS, Wu G, Kulmacz RJ, Tsai AL, Wang J.

Biochemistry. 2000 Oct 10;39(40):12424-34.

PMID:
11015223
40.

New antimicrobial flavanones from Physena madagascariensis.

Deng Y, Lee JP, Tianasoa-Ramamonjy M, Snyder JK, Des Etages SA, Kanada D, Snyder MP, Turner CJ.

J Nat Prod. 2000 Aug;63(8):1082-9.

PMID:
10978202
41.

Stereoselective diels-alder reactions of chiral anthracenes

Sanyal A, Snyder JK.

Org Lett. 2000 Aug 10;2(16):2527-30.

PMID:
10956538
42.

Remangilones A-C, new cytotoxic triterpenes from Physena madagascariensis.

Deng Y, Jiang TY, Sheng S, Tianasoa-Ramamonjy M, Snyder JK.

J Nat Prod. 1999 Mar;62(3):471-6.

PMID:
10096861
43.

Emergency nurse questions drug screening in emergency department.

Snyder JK.

J Emerg Nurs. 1987 Jul-Aug;13(4):204. No abstract available.

PMID:
3302444

Supplemental Content

Loading ...
Support Center